| Hans-Günter Meyer-Thompson | Opioide
USA. New Vaccine Technology Shows Promise as a Tool to Combat the Opioid Crisis - Experimental Vaccine Blocks Effects of Heroin in Preclinical Studies
USA. New Vaccine Technology Shows Promise as a Tool to Combat the Opioid Crisis - Experimental Vaccine Blocks Effects of Heroin in Preclinical Studies
Researchers with the U.S. Military HIV Research Program at the Walter Reed Army Institute of Research (WRAIR) report that an experimental heroin vaccine induced antibodies that prevented the drug from crossing the blood-brain barrier in mice and rats. The vaccine was co-developed at the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, which funded the preclinical research. (The U.S. Military HIV Research Program (MHRP), 18.12.2017)
https://www.hivresearch.org/sites/default/files/December%2018%20Heroin%20vaccine.pdf